Bioactivity and the first transmission electron microscopy immunogold studies of short de novo-designed antimicrobial

Marisa Ann Azad1, Heidi Esther Katrina Huttunen-Hennelly, Cynthia Ross Friedman

  • 1Department of Biological Sciences, Faculty of Science, Thompson Rivers University, 900 McGill Road, Kamloops, BC V2C 5N3, Canada.

Insights

This study explored antimicrobial peptides (AMPs) against drug-resistant pathogens. Increasing peptide hydrophobicity improved efficacy without significant toxicity, revealing a novel "floodgate" mechanism.

Area of Science:

  • Microbiology
  • Biochemistry
  • Structural Biology

Background:

  • The rise of microbial drug resistance necessitates novel therapeutic strategies.
  • Antimicrobial peptides (AMPs) are a promising class of therapeutics, but their design and mechanisms of action require further elucidation.
  • Understanding the structure-activity relationship of AMPs is crucial for developing effective treatments against multidrug-resistant (MDR) pathogens.

Purpose of the Study:

  • To investigate the relationship between sequence, higher-order structure, and mechanism of action for five designed antimicrobial peptides (AMPs).
  • To evaluate the efficacy of these AMPs against multidrug-resistant (MDR) pathogens.
  • To explore a novel AMP design principle involving N-terminal glycine residues.

Main Methods:

  • Design and synthesis of five 15-residue polycationic peptides with varying hydrophobicity.
  • Assessment of antimicrobial activity using minimum inhibitory concentrations (MICs).
  • Evaluation of hemolytic activity.
  • Adaptation and application of transmission electron microscopy (TEM) immunogold labeling to visualize AMP-bacterial interactions.
  • Structural analysis of peptide secondary structures in hydrophobic environments.

Main Results:

  • All designed peptides, except the d-amino acid substituted one, adopted alpha-helical structures in hydrophobic conditions.
  • Increasing peptide hydrophobicity significantly enhanced antimicrobial activity (MICs reduced from ≤500 μg/ml to ≤7.4 μg/ml).
  • Hemolytic activity remained low, with a maximum of 18% hemolysis at 3,400 μg/ml.
  • The study successfully employed TEM immunogold labeling to study the mechanism of action of short AMPs within bacteria.
  • A novel 'floodgate' mechanism is proposed to explain observed membrane deformation and peptide localization.

Conclusions:

  • Designed AMPs with increased hydrophobicity demonstrate potent activity against MDR pathogens with minimal hemolytic toxicity.
  • The N-terminal glycine residue represents a novel design principle for AMPs.
  • The developed TEM immunogold method is effective for studying the mechanism of action of short AMPs.
  • The proposed 'floodgate' mechanism offers new insights into AMP-bacterial membrane interactions.